Navigation Links
Anthera Announces Positive Phase II Clinical Results From A-002 Cardiovascular Disease Trial
Date:10/24/2007

cluding Japan) to a series of clinical and pre-clinical compounds that inhibit the enzymatic activity of members of the phospholipase A2 (PLA2) family - a group of enzymes responsible for the release of arachidonic acid and subsequent production of leukotrienes prostacyclins and other mediators of inflammation. These highly potent compounds inhibit novel upstream steps in the inflammation cascade and have the potential to address a variety of diseases. For more information, please visit http://www.anthera.com.

Contact:

Anne Bowdidge (650) 218-6900

pr@anthera.com


'/>"/>
SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...PRNewswire-FirstCall/--Vermillion,Inc.(VRML)(PinkS...anizationandDisclosureStatementtoday,November24,20...tofDelaware.AhearingtoconsiderapprovaloftheDisclos...withthehearingontheconfirmationofthePlanscheduledf...payallclaimsinfull.ThePlanisexpected,ifapproved,to...
(Date:11/24/2009)...wire/--Accumetrics,Inc.,aprivately-helddeveloperan...ndeasy-to-usediagnosticsystemformeasuringanindivid...ix®andaspirin),announcedtodaythatTimothyI.Sti...ts,ChiefFinancialOfficerofAccumetrics,willbepresen...ealthCareConferencebeingheldinNewYorkCityonDecembe...
(Date:11/24/2009)...wire/--AmbitBiosciencesCorporationannouncedtodayth...anovelsecondgenerationFLT3inhibitor,inAMLatthe51st...eldinNewOrleans,LA,December5-8,2009.Anoralpresenta...Imonotherapysafetystudyinadultswithacutemyeloidleu...entedevaluatingtheeffectofAC220monotherapyandincom...
Breaking Medicine Technology:Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 3Study shows how to boost value of Alzheimers fighting compounds 54660 1Study shows how to boost value of Alzheimers fighting compounds 54660 2Pitt research suggests EPA pesticide exposure test too short overlooks long term effects 9604 1Pitt research suggests EPA pesticide exposure test too short overlooks long term effects 9604 2Pitt research suggests EPA pesticide exposure test too short overlooks long term effects 9604 3Pitt research suggests EPA pesticide exposure test too short overlooks long term effects 9604 4How to make a lung 9602 1How to make a lung 9602 2
...y evaluating a clinically relevant model of,normal...t capable,of abrogating the cytotoxic effect of er...PTISOME(tm) agent was generally well,tolerated in ...,profile similar to conventional vincristine , SOU...WIRE) --,Hana Biosciences (Nasdaq:HNAB), a biophar...
... RAS data presented at ASCO , HORSOLM, Denmark, Ju...sentation titled "RAS peptide vaccination in resec...ti tumour response,and long term survival" at ASCO...cancer meeting. , A follow-up study of 23 resected...d from 1995 to 1998 with two different,peptide vac...
Other Medicine Technology:Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 2Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 3Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 4Hana Biosciences Presents Data On Two Programs At the American,Society of Clinical Oncology Annual Meeting 5Pharmexa A/S (DK) - Long lasting immune response and survival to,RAS vaccine 2
(Date:11/25/2009)... ,, LittleImprovementShownforthe4thStraigh...ire/-- Today,LungCancerAlliance-Georgia(LCA-GA)is...tisanassessmentofprogressbeingmadeagainstthisletha...CancerAlliance(LCA),theonlynationalorganizationded...plelivingwithoratriskforlungcancer. ,, (Logo: h...
(Date:11/25/2009)... , A drug used to treat colorectal cancer also ca...nsidered first-line therapy for the disease, resea...ort this week. , Mntrier,s disease causes thicken...nausea and vomiting, as well as anemia and swellin...ents are at increased risk for gastric cancer. Pre...
(Date:11/25/2009)... In mice, disks placed under the skin kill tumor ...5 (HealthDay News) -- A cancer vaccine delivered i...mors in mice, a new study reports. , The method...that are loaded with tumor-specific antigens and i...stem to attack tumors. The Harvard University scie...
(Date:11/25/2009)... , Nationwide Imaging Ser...es organizations for diagnostic imaging equipment,...pment, including financing options, service and in.... (dba Atlas Medical Technologies of California) ...er 25, 2009 -- Nationwide Imaging Services is prou...
(Date:11/25/2009)... , BioSpace.com, the prem...ion, unveiled the third edition of the BioForest&t... Englewood, CO (Vocus) November 25, 20...science careers and information, unveiled the thir...this morning., , , , ,This regional campaign is a...
Breaking Medicine News(10 mins):Health News:Lung Cancer Alliance-Georgia Issues 4th Annual State-Specific Report Card on Lung Cancer 2Health News:Vanderbilt scientists report first effective medical therapy for rare stomach disorder 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3Health News:BioSpace Showcases Leading Life-Science Companies in the Northwest 2
... Quest Diagnostics Incorporated (NYSE: DGX ), t... information and services, announced that it is sc...onference in New York City today, December 2, 2008... 2008 guidance for revenue growth of greater than ...
...ber 2008 - Elsevier announced today the publicatio... on the theme of "Second trimester abortion: women...ortion raises complex issues regarding methods, va...uctive Health Matters grew out of a conference on...
...new report from the Institute of Medicine proposes...rkloads to decrease the chances of fatigue-related...nment for these doctors in training. The report d... Education (ACGME) in 2003, but rather reduces the...
...ec. 2 Stroller Strides , the country,s largest... and their babies, has announced that Pampers ,...s signed on as the company,s premier sponsor for 2...have Pampers as our premier sponsor," said Lisa Dr...
... Study to Evaluate Efficacy of Commercially Availa...E, N.J., Dec. 2 Eisai Corporation of North Americ...rst clinical trial evaluating the activity of Daco...ic syndromes (MDS), a potentially life-threatening...
.... 2 Emdeon, a leading provider of,revenue and pay... industry,announced today the launch of an importa...care. Emdeon unveiled the U.S. Healthcare Efficien...sed,system to an electronic one. , "Through ...
Other Medicine News:Health News:Quest Diagnostics to Speak at the 20th Annual Piper Jaffray Healthcare Conference 2Health News:Elsevier announces the 2008 supplement of Reproductive Health Matters 2Health News:Revised hours and workloads for medical residents needed to prevent 2Health News:Revised hours and workloads for medical residents needed to prevent 3Health News:Stroller Strides(R) Signs Pampers(R) as Premier Sponsor for 2009 2Health News:Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes 2Health News:Eisai Will Initiate First Head-to-Head Study Comparing Dacogen(R) (decitabine for injection) and Vidaza(R) (azacitidine) in Patients with Myelodysplastic Syndromes 3Health News:Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare 2Health News:Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare 3Health News:Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare 4
R 2000Holmium:YAG Laser System
TG (Ab) RIA Thyroid Function 014-HD 27.1 Thyroglobulin
Free T4 EIA Thyroid Function 025-BC-1008
...onjugated) enzyme immunoassay (EIA) test kit is to...jugated estriol in human serum during the second h...dure is an enzyme immunoassay, which is based on t...cedure, estriol is conjugated to the enzyme,hors...
Medicine Products: